Literature DB >> 18182795

Pathophysiology of salt-sensitive hypertension: a new scope of an old problem.

Martha Franco1, Laura G Sanchez-Lozada, Rocio Bautista, Richard J Johnson, Bernardo Rodriguez-Iturbe.   

Abstract

It has been recognized for many years that salt intake is one of the main environmental factors responsible for the development of hypertension. More than 30 years ago, Guyton and co-workers postulated a relationship between blood pressure and natriuresis which maintains sodium balance and extracellular volume; thus an impaired ability of the kidney to excrete sodium requires an increase in blood pressure to increase natriuresis and correct the sodium balance, resulting in hypertension. Currently, the mechanisms responsible for the alterations mentioned above remain under investigation. Among them, microvascular and tubulointerstitial injury induce salt retention and development of salt-sensitive hypertension that appears to be mediated in part by lymphocytes and macrophages infiltrating the tubulointerstitium that produce angiotensin II and stimulate oxidative stress. In the post-angiotensin salt-sensitive hypertension model, angiotensin levels are elevated despite systemic angiotensin II levels being suppressed, and the local angiotensin II levels correlate with the presence of intrarenal inflammation and cortical vasoconstriction. Under these conditions, blockade of the angiotensin II AT1 receptors ameliorate cortical vasoconstriction. Thus, the renal angiotensin system in association with interstitial immune infiltrating cells may play a pivotal role in the development and maintenance of salt-sensitive hypertension. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182795     DOI: 10.1159/000110563

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  8 in total

1.  Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation.

Authors:  Xiaoli Zhou; Kai Chen; Han Lei; Zhongjie Sun
Journal:  J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 10.121

2.  Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis.

Authors:  Maria Picken; Jianrui Long; Geoffrey A Williamson; Aaron J Polichnowski
Journal:  Hypertension       Date:  2016-08-22       Impact factor: 10.190

3.  Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact.

Authors:  Jean-Marie Krzesinski; Eric P Cohen
Journal:  Core Evid       Date:  2010-06-15

4.  Effects of genetic counseling for hypertension on changes in lifestyle behaviors among African-American women.

Authors:  Jacquelyn Y Taylor; Chun Yi Wu
Journal:  J Natl Black Nurses Assoc       Date:  2009-07

5.  Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat.

Authors:  Md Abdul Hye Khan; Jan Neckár; Vijay Manthati; Ramu Errabelli; Tengis S Pavlov; Alexander Staruschenko; John R Falck; John D Imig
Journal:  Hypertension       Date:  2013-08-26       Impact factor: 10.190

6.  Salt-sensitive hypertension in mitochondrial superoxide dismutase deficiency is associated with intra-renal oxidative stress and inflammation.

Authors:  Kyubok Jin; Nosratola D Vaziri
Journal:  Clin Exp Nephrol       Date:  2013-08-10       Impact factor: 2.801

7.  Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.

Authors:  Marlina Manhiani; Jeffrey E Quigley; Sarah F Knight; Shiva Tasoobshirazi; TarRhonda Moore; Michael W Brands; Bruce D Hammock; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-24

Review 8.  Salt restriction in kidney disease--a missed therapeutic opportunity?

Authors:  Eberhard Ritz; Otto Mehls
Journal:  Pediatr Nephrol       Date:  2008-06-06       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.